| -0.61 / -0.50%|
The 19 analysts offering 12-month price forecasts for Valeant Pharmaceuticals International Inc have a median target of 168.00, with a high estimate of 200.00 and a low estimate of 123.00. The median estimate represents a +39.03% increase from the last price of 120.84.
The current consensus among 19 polled investment analysts is to Buy stock in Valeant Pharmaceuticals International Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.